In this arena, MBOAT7 suppression, a MAFLD progression-associated mechanism, could also be particularly implicated due to the downregulating effect of hyperinsulinemia over the gene expression, providing NAFLD progression and further cardiovascular damage [41]. The gene discussed is MBOAT7; the disease is metabolic dysfunction-associated steatotic liver disease.